You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

canakinumab

Showing 26 - 48 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schnitzler Syndrome Trial in Germany (Canakinumab, Placebo)

Completed
  • Schnitzler Syndrome
  • Canakinumab
  • Placebo
  • Berlin, Germany
  • +4 more
Jul 16, 2018

Atherosclerosis Trial in Worldwide (Canakinumab, Placebo, Standard of care)

Completed
Has Results
  • Atherosclerosis
  • Canakinumab
  • +2 more
  • Athens, Alabama
  • +1132 more
Jan 10, 2020

Gout Trial in Worldwide (Canakinumab, Colchicine, Allopurinol)

Completed
Has Results
  • Gout
  • Canakinumab
  • +4 more
  • Huntington Beach, California
  • +88 more
Jun 19, 2018

Hereditary Periodic Fevers Trial in Worldwide (Canakinumab, Placebo)

Completed
Has Results
  • Hereditary Periodic Fevers
  • Canakinumab
  • Placebo
  • Los Angeles, California
  • +64 more
Apr 6, 2018

Kawasaki Disease Trial (Canakinumab)

Withdrawn
  • Kawasaki Disease
  • Canakinumab
  • (no location specified)
Feb 15, 2017

Colchicine Resistant/Intolerant Familial Mediterranean Fever Trial in Israel (Canakinumab)

Completed
  • Colchicine Resistant/Intolerant Familial Mediterranean Fever
  • Canakinumab
  • Haifa, Israel
  • +4 more
Nov 16, 2016

Chronic Idiopathic Urticaria Trial in Zurich (Canakinumab, Placebo)

Unknown status
  • Chronic Idiopathic Urticaria
  • Canakinumab
  • Placebo
  • Zurich, Switzerland
    University Hospital Zurich, Division of Dermatology
Sep 26, 2016

Pyoderma Gangrenosum Trial in Zurich (Canakinumab)

Completed
  • Pyoderma Gangrenosum
  • Canakinumab
  • Zurich, Switzerland
    Department of Dermatology, University Hospital Zurich
Sep 26, 2016

Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Canakinumab, Placebo)

Terminated
Has Results
  • Systemic Juvenile Idiopathic Arthritis
  • Canakinumab
  • Placebo
  • Birmingham, Alabama
  • +90 more
Feb 28, 2017

Systemic Juvenile Idiopathic Arthritis Trial (ACZ885, Canakinumab)

Withdrawn
  • Systemic Juvenile Idiopathic Arthritis
  • (no location specified)
Oct 13, 2015

Mevalonate Kinase Deficiency Trial in Esplugues de Llobregat, Valencia, Madrid (Canakinumab)

Completed
Has Results
  • Mevalonate Kinase Deficiency
  • Canakinumab
  • Esplugues de Llobregat, Barcelona, Spain
  • +2 more
Oct 13, 2015

Rheumatoid Arthritis Trial in Worldwide (Canakinumab, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Canakinumab
  • Placebo
  • Anniston, Alabama
  • +16 more
Jan 14, 2014

Arthritis, Gouty Trial in Switzerland, United Kingdom, United States (biological, drug, other)

Completed
Has Results
  • Arthritis, Gouty
  • canakinumab
  • +3 more
  • Birmingham, Alabama
  • +3 more
Dec 4, 2012

Osteoarthritis Trial in Worldwide (Canakinumab, Placebo to canakinumab, Naproxen)

Completed
Has Results
  • Osteoarthritis
  • Canakinumab
  • +3 more
  • Anniston, Alabama
  • +12 more
Sep 28, 2012

Systemic Juvenile Idiopathic Arthritis With Active Flare Trial in Worldwide (canakinumab, )

Completed
Has Results
  • Systemic Juvenile Idiopathic Arthritis With Active Flare
  • canakinumab
  • placebo
  • Little Rock, Arkansas
  • +72 more
Sep 13, 2012

Schnitzler Syndrome Trial in Nijmegen (Canakinumab)

Completed
  • Schnitzler Syndrome
  • Canakinumab
  • Nijmegen, Netherlands
    Radboud University Nijmegen Medical Centre
May 23, 2012

Urticaria, Vasculitis Trial in Berlin (canakinumab)

Completed
  • Urticaria
  • Vasculitis
  • canakinumab
  • Berlin, Germany
    Charité-Universitätsmedizin Berlin
May 30, 2012

Familial Mediterranean Fever Trial in Istanbul (Canakinumab)

Completed
  • Familial Mediterranean Fever
  • Canakinumab
  • Istanbul, Turkey
    Istanbul Medical Faculty, Dept of Rheumatology, Capa
Apr 27, 2012

Acute Gout Trial in Worldwide (Canakinumab, Triamcinolone acetonide)

Completed
Has Results
  • Acute Gout
  • Canakinumab
  • Triamcinolone acetonide
  • Anniston, Alabama
  • +74 more
Apr 9, 2012

Type 2 Diabetes Trial in Germany, Russian Federation, United States (Canakinumab, Placebo, Metformin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Canakinumab
  • +2 more
  • Little Rock, Arkansas
  • +12 more
Jan 10, 2012

Diabetes, Type 2 Trial in Worldwide (Canakinumab, Metformin, Placebo)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Canakinumab
  • +2 more
  • Phoenix, Arizona
  • +105 more
Jan 17, 2012

COPD Trial in United States (Canakinumab, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Canakinumab
  • Placebo
  • Anaheim, California
  • +10 more
Jun 28, 2011

NALP3 Mutation Trial in Worldwide (canakinumab)

Completed
  • NALP3 Mutation
  • canakinumab
  • Lille, France
  • +9 more
Feb 16, 2009